ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMA (NHL) von Budde, L.E., Vallurupalli, A., Babu, S., Lossos, I.S., Alderuccio, J.P., Chavez, J.C., Eradat, H., Holmes, H., Hamadani, M., Karur, V.G., Olszewski, A.J., Seymour, E., Althaus, B., Medeiros, B.M., Li, C.C., Kwan, A., Wei, M.C., Yin, S., O'Hear, C., Munoz, J.

Volltext